These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19221203)

  • 21. [Estrogen and cardiovascular diseases].
    Mikkola T; Tikkanen MJ
    Duodecim; 2003; 119(22):2191-7. PubMed ID: 14702808
    [No Abstract]   [Full Text] [Related]  

  • 22. Women's health issues.
    Kaiser FE
    Med Clin North Am; 2003 Sep; 87(5):xi-xiii. PubMed ID: 14621323
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone replacement therapy and inflammation: interactions in cardiovascular disease.
    Miller AP; Chen YF; Xing D; Feng W; Oparil S
    Hypertension; 2003 Oct; 42(4):657-63. PubMed ID: 12913055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways.
    Leung SW; Teoh H; Keung W; Man RY
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):822-6. PubMed ID: 17600565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular aspects of menopausal hormone replacement therapy.
    Rosano GM; Vitale C; Fini M
    Climacteric; 2009; 12 Suppl 1():41-6. PubMed ID: 19811240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women.
    White RE; Gerrity R; Barman SA; Han G
    Steroids; 2010 Nov; 75(11):788-93. PubMed ID: 20060403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.
    Iorga A; Cunningham CM; Moazeni S; Ruffenach G; Umar S; Eghbali M
    Biol Sex Differ; 2017 Oct; 8(1):33. PubMed ID: 29065927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
    Meyer MR; Barton M
    Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mining the complexities of the estrogen signaling pathways for novel therapeutics.
    McDonnell DP
    Endocrinology; 2003 Oct; 144(10):4237-40. PubMed ID: 14500558
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone replacement therapy and cardiovascular health in midlife women.
    Sharts-Hopko NC
    Medsurg Nurs; 1995 Aug; 4(4):314-6. PubMed ID: 7627237
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormone in the hot seat.
    Mandavilli A
    Nat Med; 2006 Jan; 12(1):8-9. PubMed ID: 16397539
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory effects of tanshinone IIA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway.
    Liu X; Guo CY; Ma XJ; Wu CF; Zhang Y; Sun MY; Pan YT; Yin HJ
    Cell Physiol Biochem; 2015; 35(5):1744-55. PubMed ID: 25832326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone therapy and cardiovascular disease in women.
    Stefanick ML
    Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):451-8. PubMed ID: 20554177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of cardiac hypertrophy by estrogens.
    Pelzer T; Shamim A; Wölfges S; Schumann M; Neyses L
    Adv Exp Med Biol; 1997; 432():83-9. PubMed ID: 9433514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen signaling in metabolic inflammation.
    Monteiro R; Teixeira D; Calhau C
    Mediators Inflamm; 2014; 2014():615917. PubMed ID: 25400333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal.
    Störk S; van der Schouw YT; Grobbee DE; Bots ML
    Trends Endocrinol Metab; 2004 Mar; 15(2):66-72. PubMed ID: 15036252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.